Global Attention Deficit Hyperactivity Disorder (ADHD) Market Research Report 2023

Effective treatment of ADHD. ADHD refers to a group of syndromes that occur in childhood and are characterized by obvious difficulty in concentration, short duration of attention, hyperactivity or impulsivity compared with children of the same age.

The global Attention Deficit Hyperactivity Disorder (ADHD) market was valued at US$ 13130 million in 2022 and is anticipated to reach US$ 19380 million by 2029, witnessing a CAGR of 6.7% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

There are two main types of drugs used to treat ADHD: stimulants and non-stimulants

The main manufacturers of stimulants are in Europe and America, and the main manufacturers of non-stimulants are in China.

ADHD is mainly used in hospital pharmacies and retail pharmacies. Among them, in 2020, the market share of retail pharmacies accounted for approximately 83%

Takeda has the highest market share in ADHD by major global companies, which is much higher than the market share of other companies, about 21% in 2020.

This report aims to provide a comprehensive presentation of the global market for Attention Deficit Hyperactivity Disorder (ADHD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Attention Deficit Hyperactivity Disorder (ADHD).

The Attention Deficit Hyperactivity Disorder (ADHD) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Attention Deficit Hyperactivity Disorder (ADHD) market comprehensively. Regional market sizes, concerning products by type, by distribution channel, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Attention Deficit Hyperactivity Disorder (ADHD) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by distribution channel, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Stimulant

1.2.3 Non-stimulant

1.3 Market by Distribution Channel

1.3.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Growth by Distribution Channel: 2018 VS 2022 VS 2029

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Perspective (2018-2029)

2.2 Attention Deficit Hyperactivity Disorder (ADHD) Growth Trends by Region

2.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Attention Deficit Hyperactivity Disorder (ADHD) Historic Market Size by Region (2018-2023)

2.2.3 Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Region (2024-2029)

2.3 Attention Deficit Hyperactivity Disorder (ADHD) Market Dynamics

2.3.1 Attention Deficit Hyperactivity Disorder (ADHD) Industry Trends

2.3.2 Attention Deficit Hyperactivity Disorder (ADHD) Market Drivers

2.3.3 Attention Deficit Hyperactivity Disorder (ADHD) Market Challenges

2.3.4 Attention Deficit Hyperactivity Disorder (ADHD) Market Restraints

3.1 Global Top Attention Deficit Hyperactivity Disorder (ADHD) Players by Revenue

3.1.1 Global Top Attention Deficit Hyperactivity Disorder (ADHD) Players by Revenue (2018-2023)

3.1.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Players (2018-2023)

3.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Attention Deficit Hyperactivity Disorder (ADHD) Revenue

3.4 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Concentration Ratio

3.4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Attention Deficit Hyperactivity Disorder (ADHD) Revenue in 2022

3.5 Attention Deficit Hyperactivity Disorder (ADHD) Key Players Head office and Area Served

3.6 Key Players Attention Deficit Hyperactivity Disorder (ADHD) Product Solution and Service

3.7 Date of Enter into Attention Deficit Hyperactivity Disorder (ADHD) Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Historic Market Size by Type (2018-2023)

4.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Type (2024-2029)

5.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Historic Market Size by Distribution Channel (2018-2023)

5.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Distribution Channel (2024-2029)

6.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2018-2029)

6.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2018-2023)

6.4 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2018-2029)

7.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2018-2023)

7.4 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2018-2029)

8.2 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2018-2023)

8.4 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2018-2029)

9.2 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2018-2023)

9.4 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2018-2029)

10.2 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2018-2023)

10.4 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Takeda

11.1.1 Takeda Company Detail

11.1.2 Takeda Business Overview

11.1.3 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Introduction

11.1.4 Takeda Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)

11.1.5 Takeda Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Detail

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Introduction

11.2.4 Johnson & Johnson Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)

11.2.5 Johnson & Johnson Recent Development

11.3 Novartis

11.3.1 Novartis Company Detail

11.3.2 Novartis Business Overview

11.3.3 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Introduction

11.3.4 Novartis Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)

11.3.5 Novartis Recent Development

11.4 Eli Lilly

11.4.1 Eli Lilly Company Detail

11.4.2 Eli Lilly Business Overview

11.4.3 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Introduction

11.4.4 Eli Lilly Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)

11.4.5 Eli Lilly Recent Development

11.5 Tris Pharma

11.5.1 Tris Pharma Company Detail

11.5.2 Tris Pharma Business Overview

11.5.3 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Introduction

11.5.4 Tris Pharma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)

11.5.5 Tris Pharma Recent Development

11.6 Neos Therapeutics

11.6.1 Neos Therapeutics Company Detail

11.6.2 Neos Therapeutics Business Overview

11.6.3 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Introduction

11.6.4 Neos Therapeutics Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)

11.6.5 Neos Therapeutics Recent Development

11.7 Mallinckrodt

11.7.1 Mallinckrodt Company Detail

11.7.2 Mallinckrodt Business Overview

11.7.3 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Introduction

11.7.4 Mallinckrodt Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)

11.7.5 Mallinckrodt Recent Development

11.8 Amneal Pharmaceuticals

11.8.1 Amneal Pharmaceuticals Company Detail

11.8.2 Amneal Pharmaceuticals Business Overview

11.8.3 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Introduction

11.8.4 Amneal Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)

11.8.5 Amneal Pharmaceuticals Recent Development

11.9 Noven Pharmaceuticals

11.9.1 Noven Pharmaceuticals Company Detail

11.9.2 Noven Pharmaceuticals Business Overview

11.9.3 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Introduction

11.9.4 Noven Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)

11.9.5 Noven Pharmaceuticals Recent Development

11.10 Purdue Parma

11.10.1 Purdue Parma Company Detail

11.10.2 Purdue Parma Business Overview

11.10.3 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Introduction

11.10.4 Purdue Parma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)

11.10.5 Purdue Parma Recent Development

11.11 CTFH

11.11.1 CTFH Company Detail

11.11.2 CTFH Business Overview

11.11.3 CTFH Attention Deficit Hyperactivity Disorder (ADHD) Introduction

11.11.4 CTFH Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)

11.11.5 CTFH Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Stimulant

    Table 3. Key Players of Non-stimulant

    Table 4. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth by Distribution Channel (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Region (2018-2023)

    Table 8. Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Region (2024-2029)

    Table 10. Attention Deficit Hyperactivity Disorder (ADHD) Market Trends

    Table 11. Attention Deficit Hyperactivity Disorder (ADHD) Market Drivers

    Table 12. Attention Deficit Hyperactivity Disorder (ADHD) Market Challenges

    Table 13. Attention Deficit Hyperactivity Disorder (ADHD) Market Restraints

    Table 14. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Players (2018-2023)

    Table 16. Global Top Attention Deficit Hyperactivity Disorder (ADHD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Attention Deficit Hyperactivity Disorder (ADHD) as of 2022)

    Table 17. Ranking of Global Top Attention Deficit Hyperactivity Disorder (ADHD) Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Attention Deficit Hyperactivity Disorder (ADHD) Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Attention Deficit Hyperactivity Disorder (ADHD) Product Solution and Service

    Table 21. Date of Enter into Attention Deficit Hyperactivity Disorder (ADHD) Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Type (2018-2023)

    Table 25. Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Type (2024-2029)

    Table 27. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2018-2023) & (US$ Million)

    Table 28. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Distribution Channel (2018-2023)

    Table 29. Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Distribution Channel (2024-2029) & (US$ Million)

    Table 30. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Distribution Channel (2024-2029)

    Table 31. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Takeda Company Detail

    Table 47. Takeda Business Overview

    Table 48. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Product

    Table 49. Takeda Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million)

    Table 50. Takeda Recent Development

    Table 51. Johnson & Johnson Company Detail

    Table 52. Johnson & Johnson Business Overview

    Table 53. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Product

    Table 54. Johnson & Johnson Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million)

    Table 55. Johnson & Johnson Recent Development

    Table 56. Novartis Company Detail

    Table 57. Novartis Business Overview

    Table 58. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Product

    Table 59. Novartis Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million)

    Table 60. Novartis Recent Development

    Table 61. Eli Lilly Company Detail

    Table 62. Eli Lilly Business Overview

    Table 63. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Product

    Table 64. Eli Lilly Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million)

    Table 65. Eli Lilly Recent Development

    Table 66. Tris Pharma Company Detail

    Table 67. Tris Pharma Business Overview

    Table 68. Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Product

    Table 69. Tris Pharma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million)

    Table 70. Tris Pharma Recent Development

    Table 71. Neos Therapeutics Company Detail

    Table 72. Neos Therapeutics Business Overview

    Table 73. Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Product

    Table 74. Neos Therapeutics Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million)

    Table 75. Neos Therapeutics Recent Development

    Table 76. Mallinckrodt Company Detail

    Table 77. Mallinckrodt Business Overview

    Table 78. Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Product

    Table 79. Mallinckrodt Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million)

    Table 80. Mallinckrodt Recent Development

    Table 81. Amneal Pharmaceuticals Company Detail

    Table 82. Amneal Pharmaceuticals Business Overview

    Table 83. Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product

    Table 84. Amneal Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million)

    Table 85. Amneal Pharmaceuticals Recent Development

    Table 86. Noven Pharmaceuticals Company Detail

    Table 87. Noven Pharmaceuticals Business Overview

    Table 88. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product

    Table 89. Noven Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million)

    Table 90. Noven Pharmaceuticals Recent Development

    Table 91. Purdue Parma Company Detail

    Table 92. Purdue Parma Business Overview

    Table 93. Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Product

    Table 94. Purdue Parma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million)

    Table 95. Purdue Parma Recent Development

    Table 96. CTFH Company Detail

    Table 97. CTFH Business Overview

    Table 98. CTFH Attention Deficit Hyperactivity Disorder (ADHD) Product

    Table 99. CTFH Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023) & (US$ Million)

    Table 100. CTFH Recent Development

    Table 101. Research Programs/Design for This Report

    Table 102. Key Data Information from Secondary Sources

    Table 103. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type: 2022 VS 2029

    Figure 3. Stimulant Features

    Figure 4. Non-stimulant Features

    Figure 5. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Comparison by Distribution Channel (2023-2029) & (US$ Million)

    Figure 6. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Distribution Channel: 2022 VS 2029

    Figure 7. Hospital Pharmacy Case Studies

    Figure 8. Retail Pharmacy Case Studies

    Figure 9. Attention Deficit Hyperactivity Disorder (ADHD) Report Years Considered

    Figure 10. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 11. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 12. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Region: 2022 VS 2029

    Figure 13. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Players in 2022

    Figure 14. Global Top Attention Deficit Hyperactivity Disorder (ADHD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Attention Deficit Hyperactivity Disorder (ADHD) as of 2022)

    Figure 15. The Top 10 and 5 Players Market Share by Attention Deficit Hyperactivity Disorder (ADHD) Revenue in 2022

    Figure 16. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 17. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Country (2018-2029)

    Figure 18. United States Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 19. Canada Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Country (2018-2029)

    Figure 22. Germany Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. France Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. U.K. Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Italy Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Russia Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Nordic Countries Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Region (2018-2029)

    Figure 30. China Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Japan Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. South Korea Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. India Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Australia Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Country (2018-2029)

    Figure 38. Mexico Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Brazil Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Country (2018-2029)

    Figure 42. Turkey Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Saudi Arabia Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Takeda Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)

    Figure 45. Johnson & Johnson Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)

    Figure 46. Novartis Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)

    Figure 47. Eli Lilly Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)

    Figure 48. Tris Pharma Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)

    Figure 49. Neos Therapeutics Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)

    Figure 50. Mallinckrodt Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)

    Figure 51. Amneal Pharmaceuticals Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)

    Figure 52. Noven Pharmaceuticals Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)

    Figure 53. Purdue Parma Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)

    Figure 54. CTFH Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2018-2023)

    Figure 55. Bottom-up and Top-down Approaches for This Report

    Figure 56. Data Triangulation

    Figure 57. Key Executives Interviewed